Healthcare Triangle PE Ratio 2020-2025 | HCTI
Current and historical p/e ratio for Healthcare Triangle (HCTI) from 2020 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Healthcare Triangle PE ratio as of August 12, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Healthcare Triangle PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2025-08-12 | 3.04 | 0.00 | |
2025-03-31 | 74.60 | $-0.90 | 0.00 |
2024-12-31 | 245.61 | $-1.15 | 0.00 |
2024-09-30 | 122.01 | $-2.18 | 0.00 |
2024-06-30 | 128.38 | $-2.42 | 0.00 |
2024-03-31 | 463.14 | $-2.56 | 0.00 |
2023-12-31 | 683.51 | $-2.94 | 0.00 |
2023-09-30 | 948.69 | $-2.98 | 0.00 |
2023-06-30 | 580.17 | $-3.22 | 0.00 |
2023-03-31 | 999.74 | $-2.90 | 0.00 |
2022-12-31 | 447.45 | $-2.70 | 0.00 |
2022-09-30 | 923.79 | $-2.60 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.018B | $0.012B |
Healthcare Triangle Inc. is a healthcare information technology company focused on solutions in the areas of cloud services, data science, professional and managed services for the healthcare and life sciences industry. Healthcare Triangle Inc. is based in PLEASANTON, Calif. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $45.009B | 57.26 |
Doximity (DOCS) | United States | $11.611B | 51.52 |
Tempus AI (TEM) | United States | $11.485B | 0.00 |
Hims & Hers Health (HIMS) | United States | $10.735B | 88.82 |
IRhythm Technologies (IRTC) | United States | $5.216B | 0.00 |
Hinge Health (HNGE) | United States | $4.368B | 0.00 |
Privia Health (PRVA) | United States | $2.542B | 188.27 |
Inspire Medical Systems (INSP) | United States | $2.482B | 36.49 |
Phreesia (PHR) | United States | $1.657B | 0.00 |
Enovis (ENOV) | United States | $1.643B | 8.69 |
10x Genomics (TXG) | United States | $1.577B | 0.00 |
Omnicell (OMCL) | United States | $1.449B | 27.91 |
Schrodinger (SDGR) | United States | $1.383B | 0.00 |
Azenta (AZTA) | United States | $1.339B | 58.42 |
Clover Health Investments (CLOV) | United States | $1.272B | 0.00 |
Claritev (CTEV) | United States | $1.080B | 0.00 |
Evolent Health (EVH) | United States | $1.033B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.643B | 0.00 |
Veradigm (MDRX) | United States | $0.503B | 0.00 |
Standard BioTools (LAB) | United States | $0.498B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.496B | 0.00 |
Talkspace (TALK) | United States | $0.419B | 125.00 |
Carlsmed (CARL) | $0.351B | 0.00 | |
Butterfly Network (BFLY) | United States | $0.350B | 0.00 |
TruBridge (TBRG) | United States | $0.294B | 51.53 |
Nyxoah SA (NYXH) | Belgium | $0.228B | 0.00 |
Outset Medical (OM) | United States | $0.225B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.212B | 0.00 |
Health Catalyst (HCAT) | United States | $0.211B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.192B | 0.00 |
CapsoVision (CV) | United States | $0.188B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.136B | 0.00 |
American Well (AMWL) | United States | $0.110B | 0.00 |
CareCloud (CCLD) | United States | $0.107B | 4.87 |
EUDA Health Holdings (EUDA) | Singapore | $0.096B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.093B | 0.00 |
Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
Pulmonx (LUNG) | United States | $0.065B | 0.00 |
111 (YI) | China | $0.058B | 0.00 |
P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
HeartBeam (BEAT) | United States | $0.041B | 0.00 |
Zhongchao (ZCMD) | China | $0.024B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
Precipio (PRPO) | United States | $0.021B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
HeartSciences (HSCS) | United States | $0.008B | 0.00 |
Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
MSP Recovery (MSPR) | United States | $0.006B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
Movano (MOVE) | United States | $0.004B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
PROFUSA (PFSA) | United States | $0.003B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |